Skip to main content
. 2017 Apr 20;6(3):225–230. doi: 10.15171/jnp.2017.37

Table 1. Description of patients’ characteristics .

Variable Descriptive index
Age (y) 43.08±19.17
Sex
Male 12(50.0%)
Female 12(50.0%)
Inpatients 1 (4.2%)
Duration of hospitalization (days) 13.39±8.33
HTN 5( 20.8%)
Fever 9 (37.5%)
Rash 1 (4.2%)
Arthralgia 1 (4.2%)
Flank pain 7(29.2%)
Hematuria (microscopic) (>3 RBC) 17(70.8%)
Hematuria (gross) 6(25.0%‏(
Cr (admission)(mg/dL) 5.65±2.81
Cr (peak)(mg/dL) 6.24±3.59
Urine pro.24(mg/24 h) 813.16±1776.55
ESR (mm/h) 67.84±28.94
CRP(mg/L) 44.80±38.99
BUN (mg/dL) 55.66±33.02
Eosinophilia (c 0.5 × 109/L) 1 (4.2%)
Anemia 20 (83.3%)
Leukocytosis (>10.5 × 109/L) 5 (20.8%)
Pyuria (>5WBC/HPF) 15 (62.5%)
Proteinuria(>150 mg/d) 14 (58.3%)
AKIN stage
Stages 1&2 6 (25.0%)
Stage3 18 (75.0%)
Infiltration
Mild 11 (45.8%)
Moderate 3 (12.5%)
Severe 10 (41.7%)
Interstitial fibrosis 9 (37.5%)
Granuloma 1 (4.2%)
Tubular necrosis 5 (20.8%)
Interstitial edema 17( 70.8%)
Treatment
Dialysis 13 (54.2%)
Steroid 17 (70.8%)
PO 12 (70.6%)
IV 5 (29.4%)
Recovery
Complete 14 (58.3%)
Partial or none 10 (41.7%)
CKD 8 (33.3%)
ESRD 2 (8.3%)
Ultimate outcome
Normal 14 (58.3%)
CKD 8 (33.3%)
ESRD 2 (8.3%)

Quantitative variables were described using means ±SD and qualitative variable were described using frequency (%).